<DOC>
	<DOCNO>NCT00408577</DOCNO>
	<brief_summary>Impaired glucose tolerance mild glucose elevation non-diabetic range associate increase cardiovascular disease recent study suggest need detect glucose abnormality early post-infarction period . Although last ten year procedures coronary revascularisation dramatically improve outcome non diabetic patient affect ischemic heart disease , procedures less effective patient type 2 diabetes mellitus IGT . Possible cause bad prognosis patient could relate presence hyperinsulinemia insulin resistance due well know effect insulin increase neointimal tissue proliferation in-stent restenosis , stimulate vascular smooth muscle cell growth factor migration . In addition , well know endothelial dysfunction early functional disturbance development atherosclerotic lesion . The impairment eNOS action might change turnover rate eNOS nitric oxide production action influence nitric oxide signal , apoptosis cascade angiogenesis . All factor contribute endothelial dysfunction certain extent , accelerate atherosclerosis increase risk cardiovascular disease . The constitutively express eNOS , likely major contributor whole-body nitric oxide production . It interesting note region chromosome 7q seem influence insulin resistance blood pressure , suggest locus may broadly influence trait associate insulin resistance . L-arginine essential amino acid availability important normal endothelial cell function intracellular reduction may contribute dysfunctional endothelial state . It well know L-arginine precursor nitric oxide vitro vivo study demonstrate L-arginine augment vascular dilation certain condition . Our hypothesis evaluate modulate effect L-arginine metabolic , endothelial variable myocardial function patient cardiovascular disease .</brief_summary>
	<brief_title>Prevention Cardiac Vascular Events Patients With NGT/IGT .</brief_title>
	<detailed_description>Condition : Patients submit coronary revascularization characterize glucose tolerance OGTT Intervention : L-arginine 6 month Inclusion criterion : patient stable clinical condition coronary revascularization ( CABG percutaneous angioplasty with/without stent implantation ) . Age &gt; 30 year , male female . Fasting glucose level 126 mg/dl . Exclusion criterion . Type 1 diabetes mellitus , know type 2 diabetes mellitus , pregnancy , impaired kidney liver function , severe treat arterial hypertension . Study type : randomize , double blind , Placebo , parallel</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>patient stable clinical condition coronary revascularization ( CABG percutaneous angioplasty with/without stent implantation ) . Age &gt; 30 year , male female . Fasting glucose level 126 mg/dl . Type 1 diabetes mellitus , know type 2 diabetes mellitus , pregnancy , impaired kidney liver function , severe treat arterial hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>glucose intolerance</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>endothelial dysfunction</keyword>
</DOC>